TerminatedNot Applicable

Study of Biologic Materials From the Mediastinal Lymph Nodes From Patients With Lung Disease.

Stopped: Study was terminated due to lack of funding.

United States56 participantsStarted 2011-08-16

Plain-language summary

The purpose of this protocol is to obtain biologic materials from the mediastinal lymph nodes from patients with lung disease and mediastinal lymph node involvement in order to: (1) develop a better understanding of the cause and development of lung disorders involving the mediastinal lymph nodes; (2) identify biologic parameters that help diagnose and predict the behavior of human lung diseases; and (3) identify individuals who will be suitable candidates for other protocols such as those involving investigational new drugs.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. symptoms consistent with pulmonary disease
✓. chest X-ray and chest CT and/or PET CT scan consistent with lung disease and mediastinal lymph node involvement
✓. lung biopsy consistent with lung disease known to involve mediastinal lymph nodes
✓. patients with diseases of organs with known association to lung disease and mediastinal lymph node involvement.

What they're measuring

Evidence that is consistent with lung disease and presentation of enlarged mediastinal lymph nodes

Timeframe: 24 Hours

Trial details

NCT IDNCT02168036

SponsorWeill Medical College of Cornell University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-02-06

View on ClinicalTrials.gov More Lung Disease trials